TRX Gold Corporation (TRX)
NYSEAMERICAN: TRX · Real-Time Price · USD
0.3503
-0.0187 (-5.07%)
Aug 13, 2025, 2:47 PM - Market open
Achilles Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Achilles Therapeutics stock has a target of 1.10, which predicts a 214.02% increase from the current stock price of 0.35.
Price Target: $1.10 (+214.02%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Achilles Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1 → $1.1 | Strong Buy | Maintains | $1 → $1.1 | +214.02% | Jul 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $1.4 → $1.5 | Strong Buy | Reiterates | $1.4 → $1.5 | +328.20% | Dec 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $1.4 | Strong Buy | Reiterates | $1.4 | +299.66% | Jul 16, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $1.5 → $1.75 | Strong Buy | Maintains | $1.5 → $1.75 | +399.57% | Apr 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.3 → $1.4 | Strong Buy | Maintains | $1.3 → $1.4 | +299.66% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
50.89M
from 41.16M
Increased by 23.64%
Revenue Next Year
77.23M
from 50.89M
Increased by 51.77%
EPS This Year
0.05
from -0.00
EPS Next Year
0.07
from 0.05
Increased by 30.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 53.7M | 82.4M |
| Avg | 50.9M | 77.2M |
| Low | 48.7M | 73.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 30.4% | 61.8% |
| Avg | 23.6% | 51.8% |
| Low | 18.3% | 43.5% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | 0.07 | 0.07 |
| Avg | 0.05 | 0.07 |
| Low | 0.03 | 0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | 45.5% |
| Avg | - | 30.0% |
| Low | - | 16.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.